ArticleThe Lancet. Oncology2021
Global cancer research in the post-pandemic world.
Article in The Lancet. Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Article
- Real-world single-center data analysis of dual immunotherapy in advanced NSCLC: Efficacy, survival, and adverse events.Human vaccines & immunotherapeutics · 2025Article
- Kinesiological insights into exercise prescription within oncological prehabilitation: current knowledge and future perspectives.Frontiers in sports and active living · 2025Article
- Correlation between blood albumin and hospital death and long-term death in ICU patients with heart failure: data from the medical information mart for intensive care III database.American journal of cardiovascular disease · 2024Article
- Cancer Research Challenges and Potential Solutions in Saudi Arabia: A Qualitative Discussion Group Study.JCO global oncology · 2024Article
- Sex and authorship in global cancer research.BMJ oncology · 2024Article
- Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post-COVID-19 Global Context: A Modified Delphi Consensus Process.JCO global oncology · 2023Article
- Auxiliary Diagnosis and Prognostic Value of Dehydrogenase/Reductase 2 (DHRS2) in Various Tumors.Iranian journal of public health · 2023Article
- An analysis of the African cancer research ecosystem: tackling disparities.BMJ global health · 2023Article
- Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement.The Lancet. Oncology · 2022Article
- The global power of oncology nurses in low- and middle-income countries.Asia-Pacific journal of oncology nursing · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.